117-38-4

Basic information

• Product Name: [(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)amino]methanesulfonic acid
• Synonyms: [(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)amino]methanesulfonic acid
• CAS NO: 117-38-4
• Molecular Formula: C12H15N3O4S
• Molecular Weight: 297.33
• Mol File: 117-38-4.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• Density: 1.50±0.1 g/cm3(Predicted)
• PKA: 1.19±0.50(Predicted)
• CAS DataBase Reference: [(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)amino]methanesulfonic acid(CAS DataBase Reference)
• NIST Chemistry Reference: [(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)amino]methanesulfonic acid(117-38-4)
• EPA Substance Registry System: [(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)amino]methanesulfonic acid(117-38-4)

Safety Data

• Hazardous Substances Data: 117-38-4(Hazardous Substances Data)

Usage

General Description

[(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)amino]methanesulfonic acid, also known as MTA, is a synthetic compound with potential anti-cancer and anti-inflammatory properties. It is a small molecule inhibitor that acts on the enzyme MTA phosphorylase, which plays a role in the synthesis of DNA and RNA. MTA has been studied for its potential use in cancer treatment, as it has been shown to inhibit cancer cell growth and promote apoptosis. Additionally, MTA has been investigated for its anti-inflammatory effects, as it has been shown to suppress the expression of inflammatory cytokines and chemokines. Overall, [(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)amino]methanesulfonic acid shows promise as a therapeutic agent for both cancer and inflammatory diseases.